Carnegie Pharmaceuticals LLC
9 drugs in NADAC|7 Generic,2 Brand
Carnegie Pharmaceuticals LLC lists 9 NDCs in the CMS NADAC file (7 generic, 2 brand), at an average NADAC of $1.30 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
9
7G / 2B
Avg Price / Unit
$1.2951
$0.09 – $6.31
Avg 7d Change
-0.09%
Across 7 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Primidone market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Anti-epileptic Agent therapeutic class
Review the broader class where Carnegie Pharmaceuticals LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Carnegie Pharmaceuticals LLC make?
Carnegie Pharmaceuticals LLC lists 9 NDCs in the CMS NADAC file — 7 generic and 2 brand products.
What is the average price of Carnegie Pharmaceuticals LLC drugs?
The average NADAC across Carnegie Pharmaceuticals LLC's portfolio is $1.2951 per unit, ranging from $0.0914 to $6.3072.
What types of drugs does Carnegie Pharmaceuticals LLC make?
Carnegie Pharmaceuticals LLC makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are Anti-epileptic Agent (3), Macrolide Antimicrobial (2), Macrolide (2), Antifibrinolytic Agent (1), Aminosalicylate (1).
Has Carnegie Pharmaceuticals LLC had any drug recalls?
No FDA enforcement recalls are matched to Carnegie Pharmaceuticals LLC in the openFDA feed.
How has Carnegie Pharmaceuticals LLC's pricing changed recently?
Over the past 7 days, 2 Carnegie Pharmaceuticals LLC products rose and 5 fell, with a portfolio-wide average change of -0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ERYPED 400 MG/5 ML SUSPENSION Erythromycin Ethylsuccinate | $6.3072 per ML | — |
E.E.S. 200 MG/5 ML SUSPENSION Erythromycin Ethylsuccinate | $3.6046 per ML | — |
AMINOCAPROIC ACID 0.25 GRAM/ML AMINOCAPROIC ACID | $0.5736 per ML | -0.89% |
BALSALAZIDE DISODIUM 750 MG CP balsalazide disodium | $0.3443 per EA | -2.88% |
CLINDAMYCIN PHOS 1% PLEDGET Clindamycin Phosphate Topical | $0.2854 per EA | +0.50% |
PRIMIDONE 250 MG TABLET Primidone | $0.2276 per EA | +3.61% |
FAMOTIDINE 40 MG/5 ML SUSP FAMOTIDINE | $0.1305 per ML | -0.53% |
PRIMIDONE 50 MG TABLET Primidone | $0.0914 per EA | -0.21% |
PRIMIDONE 50 MG TABLET Primidone | $0.0914 per EA | -0.21% |